In addition, knockdown of ERα expression with ERα‐shRNA significantly decreased the number of viable ZR‐75‐1/R and MCF‐7/R cells (Figure 5F and G), indicating that IBC could down‐regulate CD44 expression by the ERα pathway to sensitize of resistant breast cancer cells to paclitaxel. Here, ESR1 is linked to breast cancer.